OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
163
Results
Show all
Save search
Copy query
Show results for
Unknown
(161)
Genomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(1)
MassIVE
(1)
Instrument Platform
Illumina Genome Analyzer IIx
(1)
Orbitrap Fusion
(1)
Publication Date
2022
(1)
Study type
DNA-seq
(1)
Release Date
2022
(27)
2021
(23)
2025
(21)
2024
(20)
2023
(13)
2020
(12)
2019
(12)
2014
(6)
2016
(5)
2015
(5)
2017
(4)
2026
(3)
2018
(3)
2010
(2)
2009
(2)
2013
(1)
2012
(1)
2011
(1)
2008
(1)
Previous
page
1 / 17
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
17
Next
page
Sort
by:
Relevance
Page size
10
Guselkumab in Biologic-Naive Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials.
Not available
S-EPMC11557812
|
biostudies-literature
Cite
A novel use for the biodegradable temporizing matrix.
Not available
S-EPMC9134145
|
biostudies-literature
Cite
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.
Not available
S-EPMC9310247
|
biostudies-literature
Cite
Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability.
Not available
S-EPMC12313752
|
biostudies-literature
Cite
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled Study.
Not available
S-EPMC11638138
|
biostudies-literature
Cite
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.
Not available
S-EPMC11269379
|
biostudies-literature
Cite
A Prospective Longitudinal Study to Demonstrate the Utility of the Palliative Prognostic Index in Forecasting the Short-term Survival of Patients with Advanced Cancer in India.
Not available
S-EPMC11618672
|
biostudies-literature
Cite
Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis.
Not available
S-EPMC12450178
|
biostudies-literature
Cite
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.
Not available
S-EPMC3329231
|
biostudies-literature
Cite
Transcatheter closure of atrial septal defect device-related aortic erosion in a pediatric patient.
Not available
S-EPMC12931620
|
biostudies-literature
Cite
Previous
page
1 / 17
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
17
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets